Related Experiment Video
Updated: Jun 11, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Recent Trends in Seroprevalence of Celiac Disease at a Tertiary Care Center
Parul Punia1, Kiran Bala1, Ankita Nandi1
1Department of Microbiology, PGIMS, Rohtak, Haryana, India.
Abstract:
It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.1, 1.62, 0.72, and 3.3%, respectively.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.